References
- Speers WC. Conversion of malignant embryonal carcinoma to benign teratoma by chemical induction of differentiation in vivo. Cancer Res, accepted for publication. 1982
- Speers WC, Altmann M. Chemically induced differentiation of murine embryonal carcinoma in vivo: Transplantation of differentiated tumors. Cancer Res 1984; 44: 2129–2135
- Speers WC, Altmann M. Malignant neoplasms of differentiated cells occurring after retinoic acid treatment of murine embryonal carcinomas in vivo. Cancer Res 1984; 44: 2136–2143
- Spremulli EN, Dexter DL. Polar solvents: A novel class of antineoplastic agents. J Clin Oncol 1984; 2: 227–241
- Friend C, Scher W, Holland JG, Sato T. Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: Stimulation of erythroid differenciation by dimethyl sulfoxide. Proc Natl Acad Sci USA 1971; 68: 378–382
- Tanaka, M, Levy, J, Terada, M, et al. Induction of erythroid differentiation in murine virus infected erythroleukemia cells by highly polar compounds. Proc Natl Acad Sci USA 1975; 72: 1003–1006
- Jakob, H, Dubois, P, Eisen, H, et al. Effects de l'hexamethylenebisacetamide sur la differentiation de cellules de carcinome embryonnaire. C R Acad Sci Paris 1978; 286: 109–111
- Speers WC, Birdwell CR, Dixon FJ. Chemically induced bidirectional differentiation of embryonal carcinoma cells in vitro. Am J Path 1979; 97: 563–584
- Jakob, H, Boon, T, Gaillard, J, et al. Terato-carcinoma de la souris: isolement, culture et proprietes de cellules a potentialites multiples. Ann Microbiol (Institut Pasteur) 1973; 124B: 269–282
- Rimm, AA, Hartz, AJ, Kalbfleisch, JH, et al. Basic Biostatistics in Medicine and Epidemiology. Appleton Century Crofts, New York 1980; 272–276
- Orr, DW, Ettinger, DS, Rice, AP, et al. Phase I and pharmacokinetic study of N-methylformamide (NMF). Proc Am Soc Clin Oncol 1983; 2: 24–24, (abst)
- National Cancer Institute clinical brochure: N-Methylformamide (NMF). National Cancer Institute, NSC 3051, Bethesda, MD June, 1982
- Pierce GB, Speers WC. Tumors as caricatures of the process of tissue renewal: Prospects for therapy by directing differentiation. Cancer Res 1988; 48: 1996–2004
- Waxman S, Takaku F. The incorporation of differentiation induction into the design of cancer therapy. The Status of Differentiation Therapy of Cancer, S Waxman, GB Rossi, F Takaku. Raven Press, New York 1988; 45: 407–419, In
- Egorin MJ. Clinical trials of polar differentiation agents. The Status of Differentiation Therapy of Cancer, S Waxman, GB Rossi, F Takaku. Raven Press, New York 1988; 45: 389–404, In